Andre A Konski
Andre A Konski, M.D.,MBA, MA, MSc
Professor of Clinical Radiation Oncology
Medical Director/ Radiation oncology, The Chester County Hospital
701 E Marshall St.
West Chester, PA
Member Cancer Committee, The Chester County Hospital
Senior Fellow, Leonard Davis Institute of Health Economics
The Chester County Hospital Executive Committee, The Chester County Hospital
Cancer executive committee, The Chester County Hospital
Department: Radiation Oncology
Contact information
Chester County Hospital
701 East Marshall St.
West Chester, PA 19380
701 East Marshall St.
West Chester, PA 19380
Office: 610 431 5530
Lab: 610 431 5530
Lab: 610 431 5530
Email:
Andre.Konski@uphs.upenn.edu
Andre.Konski@uphs.upenn.edu
Education:
BA (Biology)
Saint Michael's College, Winooski, VT, 1980.
MD
New York Medical College, Valhalla, N.Y., 1984.
MBA
University of Toledo, Toledo, Ohio, 1995.
MA (Economics)
University of Toledo, Toledo, Ohio, 1998.
PG cert (Health Economics for Healthcare professionals)
University of York, 2020.
PG Diploma (Health Economics for Healthcare Professionals)
University of York, 2021.
MSc (Economic Evaluation for Health Technology Assessment)
University of York, 2022.
Permanent linkBA (Biology)
Saint Michael's College, Winooski, VT, 1980.
MD
New York Medical College, Valhalla, N.Y., 1984.
MBA
University of Toledo, Toledo, Ohio, 1995.
MA (Economics)
University of Toledo, Toledo, Ohio, 1998.
PG cert (Health Economics for Healthcare professionals)
University of York, 2020.
PG Diploma (Health Economics for Healthcare Professionals)
University of York, 2021.
MSc (Economic Evaluation for Health Technology Assessment)
University of York, 2022.
Selected Publications
Uri Amit, James M Metz, John P Plastaras, Rohi Gheewala, Ursina Teitelbaum, Nevena Damjanov, Charles Vollmer, Charles J Schneider, Major Kenneth Lee, Mark O'Hara, Kim Reiss-Binder, Erica L Carpenter, Thomas B Karasic, Andre Konski, E Paul Wileyto, Edgar Ben-Josef: A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer. Cancer 131(12): 35936, Jun 2025.Cristina DeCesaris, Trevor Wilson, Jaewhan Kim, Lindsay Burt, Jonathan Grant, Matthew M Harkenrider, Jessica Huang, Anuja Jhingran, Elizabeth Kidd, Andre Konski, Lilie Lin, William Small Jr, Gita Suneja, David Gaffney: Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol 14(6): e500-506, Nov-Dec 2024.
Lisa A Kachnic , Kathryn Winter, Mohan Suntharalingam, David Ilson, André Konski, Shane Lloyd, Sarah A McAvoy, Thomas Lad, Olugbenga Gbenga Olowokure, Pamela Samson, Elizabeth M Gore , Joshua E Meyer, Gregory M M Videtic, David A Clump, Adam Raben, Omar Kayaleh, Jerry Barker Jr, Michael G Haddock, Judith O Hopkins, Deborah W Bruner: Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery. Qual Life Res 33(10): 2833-2844, Oct 2024.
Michelle Iocolano MD1, Nikhil Yegya-Raman MD1, Cole Friedes MD1, Xingmei Wang MS2, Timothy Kegelman MD, PhD3, Sang Ho Lee PhD4, Lian Duan MS4,5, Bolin Li BS4, William P. Levin MD1, Keith A. Cengel MD PhD1, Andre Konski MD1,6, Corey J. Langer MD7, Roger B. Cohen MD7, Lova Sun MD7, Charu Aggarwal MD7, Abigail Doucette MPH8, Ying Xiao PhD4, Boon-Keng Kevin Teo PhD4, Shannon O’Reilly PhD4, Wei Zou PhD4, Jeffrey D. Bradley MD1, Charles B. Simone II MD9 & Steven J. Feigenberg MD1: Acute Hospitalizations after Proton Therapy versus Intensity-Modulated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer in the Durvalumab Era. Cancer 130(11): 2031-2041, June 2024.
Buyyounouski MK, Pugh SL, Chen RC, Mann MJ, Kudchadker RJ, Konski AA, Mian OY, Michalski JM, Vigneault E, Valicenti RK, Barkati M, Lawton CAF, Potters L, Monitto DC, Kittel JA, Schroeder TM, Hannan R, Duncan CE, Rodgers JP, Feng F, Sandler HM.: Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms: The NRG-GU003 Phase 3 Randomized Clinical Trial. JAMA Oncol 10(5): 584-591, May 2024.
Konski A, Deshmukh S, Klopp AH, Yeung AR, Westin SN, Thompson JS, Doncals DE, Cantuaria GHC, D'Souza DP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW: Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203. Gynecol Oncol 175: 176-181, Aug 2023.
Jimmy J Caudell 1, Pedro A Torres-Saavedra 2, David I Rosenthal 3, Rita S Axelrod 4, Phuc Felix Nguyen-Tan 5, Eric J Sherman 6, Randal S Weber 3, James M Galvin 7, Adel K El-Naggar 3, Andre A Konski 8, Michelle I Echevarria 9, Neal E Dunlap 10, George Shenouda 11, Anurag K Singh 12, Jonathan J Beitler 13, Adam Garsa 14, James A Bonner 15, Adam S Garden 3, Ozer Algan 16, Jonathan Harris 2, Quynh-Thu Le: Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer. Int J Radiat Oncol Biol Phys 116(3), July 2023.
Vinai Gondi 1, Snehal Deshmukh 2, Paul D Brown 3, Jeffrey S Wefel 4, Terri S Armstrong 5, Wolfgang A Tome 6, Mark R Gilbert 4, Andre Konski 7, Clifford G Robinson 8, Joseph A Bovi 9, Tammie L S Benzinger 8, David Roberge 10, Vijayananda Kundapur 11, Isaac Kaufman 12, Sunjay Shah 13, Kenneth Y Usuki 14, Andrew M Baschnagel 15, Minesh P Mehta 16, Lisa A Kachnic: Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms with Hippocampal Avoidance during Whole-Brain Radiotherapy for Brain Metastases: Final Results of NRG Oncology CC001. Int J Radiat Oncol Biol Phys Page: S0360-3016, May 2023.
Lexi Lazar 1, Casey Hollawell 2, Neil K Taunk 2, Andre A Konski 3, Taoran Li 2, Emily Hubley 2, Shibu Anamalayil 2, Christopher Kennedy 2, Gary M Freedman : Pneumothorax Associated With Deep Inspiration Breath Holding During Radiation Therapy for Breast Cancer. Pract Radiat Oncol 13(2): e99-e102, March-April 2023.
Yeung, A.R., Deshmukh, S., Kloop, A., Gil, K., Wenzel, L., Westin, S.N., Konski, A., Thompson, J.S., Doncals, D.E., Cantuaria, G.H.C., D’Souza, D.P., Chang, A., Kundapur, V., Mohan, D.S., Hass, M.L., Kim, Y.B., Ferguson, C.L., Pugh, S.L., Kachnic, L.A., Bruner, D: Intensity-modulated radiation therapy reduces patient-reported chronic toxicity compared to conventional pelvic radiation therapy: Updated results of a randomized phase III trial. Journal of Clinical Oncology Sept 2022 Notes: Accepted for publication.